Wilmington Savings Fund Society FSB Grows Position in The Clorox Company (NYSE:CLX)

Wilmington Savings Fund Society FSB boosted its holdings in The Clorox Company (NYSE:CLX) by 6.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,072 shares of the company’s stock after buying an additional 706 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Clorox were worth $1,798,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Catalyst Capital Advisors LLC purchased a new position in shares of Clorox during the third quarter valued at approximately $54,000. Los Angeles Capital Management LLC raised its stake in Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after buying an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares during the period. Natixis Advisors LLC boosted its stake in shares of Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $148.51 on Monday. The business’s 50-day simple moving average is $161.06 and its two-hundred day simple moving average is $158.88. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The stock has a market cap of $18.38 billion, a PE ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm posted $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. Clorox’s dividend payout ratio is 133.33%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Finally, Barclays boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.